The goal of this observational study is to learn about toxicities and cosmetic outcomes in breast cancer patients treated with hypofractionated radiotherapy. The main question it aims to answer are: * Changes in breast skin * Factors related to breast skin changes * Patient-reported outcomes * Cosmetic outcomes Participants will be assessed by multi-dimensional methods before and after radiotherapy: * Photographs * Fibrometer * Questionnaires (BREAST-Q) * CTCAE version 4.03 evaluated by treating physicians
Age range
18 Years – 85 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change of cosmesis from baseline
Timeframe: After 2-3 weeks after the start of radiation therapy (During radiation therapy)
Change of cosmesis from baseline
Timeframe: 2-3 weeks after the completion of radiation therapy
Change of cosmesis from baseline
Timeframe: 6 months after radiation therapy
Change of cosmesis from baseline
Timeframe: 1 year after radiation therapy
Change of cosmesis from baseline
Timeframe: 2 year after radiation therapy
Change of cosmesis from baseline
Timeframe: 5 year after radiation therapy
Change of fibrosis from baseline
Timeframe: After 2-3 weeks after the start of radiation therapy (During radiation therapy)
Change of fibrosis from baseline
Timeframe: 2-3 weeks after the completion of radiation therapy
Change of fibrosis from baseline
Timeframe: 6 months after radiation therapy
Change of fibrosis from baseline
Timeframe: 1 year after radiation therapy
Change of fibrosis from baseline
Timeframe: 2 year after radiation therapy
Change of fibrosis from baseline
Timeframe: 5 year after radiation therapy
Change of patient-reported outcome from baseline
Timeframe: After 2-3 weeks after the start of radiation therapy (During radiation therapy)
Change of patient-reported outcome from baseline
Timeframe: 2-3 weeks after the completion of radiation therapy
Change of patient-reported outcome from baseline
Timeframe: 6 months after radiation therapy
Change of patient-reported outcome from baseline
Timeframe: 1 year after radiation therapy
Change of patient-reported outcome from baseline
Timeframe: 2 year after radiation therapy
Change of patient-reported outcome from baseline
Timeframe: 5 year after radiation therapy
Physician assessed toxicity
Timeframe: After 2-3 weeks after the start of radiation therapy
Physician assessed toxicity
Timeframe: 2-3 weeks after the completion of radiation therapy
Physician assessed toxicity
Timeframe: 6 months after radiation therapy
Physician assessed toxicity
Timeframe: 1 year after radiation therapy
Physician assessed toxicity
Timeframe: 2 year after radiation therapy
Physician assessed toxicity
Timeframe: 5 year after radiation therapy